AARD

AARD R&D Expenses

$55.06MTTM · USD

Period ending:

AARD FY R&D ExpensesUSD
AARD FY R&D Expenses2022-12-31: $7.17M2023-12-31: $4.48M2024-12-31: $17.36M2025-12-31: $48.94M$48.94M$0.00
2022-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

AARD r&d expenses history

Research and development spending. The available annual fiscal periods series contains 4 observations from Dec 31, 2022 to Dec 31, 2025.

Aardvark Therapeutics Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
48,936,000
17,363,000
4,480,000
7,172,000

Compare r&d expenses

All AARD financial metrics · AARD stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.